BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 119962
Published online Sep 25, 2026. doi: 10.5527/wjn.119962
Table 2 Clinical characteristics of included patients, mean ± SD/n (%)
Item
n = 60
Dialysis vintage (years)5.7 ± 4.2
AccessA-V shunt58 (95.6)
Permcath2 (4.4)
ESRD etiologyAnalgesic nephropathy5 (5.6)
Diabetic nephropathy11 (12.2)
Glomerulonephritis11 (12.2)
Hypertensive nephropathy19 (21.1)
Obstructive uropathy5 (5.6)
Systemic lupus erythematosus3 (3.3)
Urinary tract infection4 (4.4)
Unknown2 (2.2)
ComorbiditiesDiabetes mellitus14 (23.3)
Hypertension42 (70)
Ischemic heart disease14 (23.3)
Cerebrovascular disease1 (1.7)
Heart failure6 (6.7)
Interdialytic weight gain2.58 ± 0.65
12 (3.3)
229 (48.3)
326 (28.9)
43 (3.3)
Medications usedIntravenous iron24 (26.7)
Ator12 (13.3)
Cinacalcet8 (8.9)
One-alpha30 (33.3)


Write to the Help Desk